JianjunZhangMD

PubMed

• Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types.
  Xunhui Cai, Jennifer Y Cho, Lijun Chen, Yufeng Liu, Fenghu Ji
  Iscience. 2025-04-18
• Associations between serum micronutrients and all-cause, cancer, and cardiovascular mortality in a national representative population: Mediated by inflammatory biomark...
  Chunliang Liu, Harrison Wongsonegoro, Tianchen Sheng, Hao Fan, Jianjun Zhang
  Redox Biology. 2025-04-01
• Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report.
  Bingnan Zhang, Komal B Shah, Mitchell Parma, Kaiwen Wang, Eric K Singhi
  Journal of Thoracic Oncology. 2025-03-24

Journal Articles

• Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer (NSCLC)  
  Xiuning Le, Jianjun Zhang, John V Heymach, Clinical Lung Cancer
• Profiles of Brain Metastases: Prioritization of Therapeutic Targets  
  Raymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
• Landscape of EGFR -Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Post-Progression in EGFR-Mutant NSCLC  
  Stephen G Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach, Jack A Roth, Jianjun Zhang, William N William, Bonnie S Glisson, Clinical Cancer Research

Lectures

• Association of detection of aflatoxin in plasma of Kenyan women with increased detection of oncogenic HPV. 
  2019 ASCO Annual Meeting - 6/1/2019